31 – 40 of 152
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Impact of baseline COPD symptom severity on the benefit from dual versus mono-bronchodilators : an analysis of the EMAX randomised controlled trial
- Contribution to journal › Article
-
Mark
Reduced variability of endurance time in new protocols for exercise tests in COPD
- Contribution to journal › Article
-
Mark
Salbutamol use in relation to maintenance bronchodilator efficacy in COPD : a prospective subgroup analysis of the EMAX trial
- Contribution to journal › Article
-
Mark
Management and risk of mortality in patients hospitalised due to a first severe COPD exacerbation
- Contribution to journal › Article
-
Mark
The Swedish National Airway Register (SNAR) : development, design and utility to date
- Contribution to journal › Article
-
Mark
Hypercapnia in advanced chronic obstructive pulmonary disease : A secondary analysis of the national emphysema treatment trial
- Contribution to journal › Article
-
Mark
Early Predictors of Mortality in Patients with COPD, in Relation to Respiratory and Non-Respiratory Causes of Death - A National Register Study
- Contribution to journal › Article
-
Mark
Geographical and sociodemographic differences in discontinuation of medication for chronic obstructive pulmonary disease – a cross-classified multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA)
- Contribution to journal › Article
-
Mark
Eosinophils, basophils, and type 2 immune microenvironments in COPD-affected lung tissue
- Contribution to journal › Article
-
Mark
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD : a post hoc analysis of the EMAX randomised controlled trial
- Contribution to journal › Article
